By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Science Briefing

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - Science Briefing

Medicine

Science Briefing

Last updated: May 30, 2026 7:03 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE
[SUBJECT here]
Tau PET Underscores Medial Temporal Lobe Pathology in Alzheimer’s Disease


Medicine · Neurology

This clinicopathological study correlated in vivo 18F-flortaucipir (FTP) tau PET scans with whole-brain postmortem immunohistochemical (IHC) tau density maps in two Alzheimer’s disease cases at Braak stages IV and VI. Researchers found that FTP standardized uptake value ratios (SUVRs) showed a significant correlation only with AT8-positive tau in the more advanced Braak VI case. The results reveal that FTP PET systematically underestimates the severity of medial temporal lobe tau burden, a critical region for early disease progression, which may confound the evaluation of tau-targeted therapies.

Novelty: 88%

Rigor: 92%

Significance: 90%

Validity: 85%

Clarity: 91%


Read the paper →



Update Your Briefing Preferences

Stay curious. Stay informed —

Science Briefing

Your briefing is personalized based on your selected fields, keywords, and research interests.

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Today’s Renewable Energy Science Briefing | May 30th 2026, 9:00:19 am
Next Article Science Briefing
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

Science Briefing

The Long Road to Recovery After Cardiac Arrest

Today’s Public Health Science Briefing | May 3rd 2026, 9:00:06 am

This week’s Medicine Key Highlights

A new cascade nanoreactor for targeted cancer therapy

A Sheepish Model for Neurodevelopmental Disorders

The Lupus Nephritis Conundrum: Rethinking Risk in Low-Grade Proteinuria

A Delayed Diagnosis: When HIV Dementia Masquerades as Depression

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Natural Language Processing
  • Chemistry
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?